Xinke Capital key facts
- Xinke Capital is a other based in Xi'an, China with 10 tracked portfolio companies.
- Notable positions include CXMT Corporation (SHG: 688825), Xi'an MicroPace MedTech, AICSEMI.
- PrivateMarketView records 2 deal participations by Xinke Capital.
- Xinke Capital’s most recent recorded investment was in Jun 2021.
About Xinke Capital
Xinke Capital is a direct investment firm based in Xi'an, China. Established in 2020, the firm focus on venture capital funds; venture capital investment fund of funds. The assets are managed by the executive management team.
Investment activity
Xinke Capital joined 1 recorded round in the last two years. By year: 1 in 2026 and 1 in 2021. 1 round landed in the last 90 days. Most recently: Yanwei Semiconductor (Series B, Aug 2026) and CXMT Corporation (SHG: 688825) (Series B, Jun 2021).
Xinke Capital portfolio at a glance
10 portfolio companies are on record for Xinke Capital, including CXMT Corporation (SHG: 688825), Xi'an MicroPace MedTech and AICSEMI.
3 of the 10 carry a recorded valuation.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 10 recorded positions
- ·Watchlist + alerts for Xinke Capital's activity
Portfolio
10 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| CXMT Corporation (SHG: 688825) | — | ▮ | ▮ | ▮ |
| Xi'an MicroPace MedTech | — | ▮ | ▮ | ▮ |
| AICSEMI | — | ▮ | ▮ | ▮ |
+ 7 more companies · all 10, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Xinke Capital recent deals
2 recordedMembership and data by Private Market View
Frequently asked about Xinke Capital
- What companies does Xinke Capital invest in?
- Xinke Capital has 10 recorded portfolio companies, including CXMT Corporation (SHG: 688825), Xi'an MicroPace MedTech, AICSEMI.
- Is Xinke Capital actively investing?
- Xinke Capital's most recent recorded investment was in Jun 2021.